GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » EV-to-FCF

CK Life Sciences International Holdings (HKSE:00775) EV-to-FCF : 17.04 (As of Apr. 30, 2024)


View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CK Life Sciences International Holdings's Enterprise Value is HK$8,763 Mil. CK Life Sciences International Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$514 Mil. Therefore, CK Life Sciences International Holdings's EV-to-FCF for today is 17.04.

The historical rank and industry rank for CK Life Sciences International Holdings's EV-to-FCF or its related term are showing as below:

HKSE:00775' s EV-to-FCF Range Over the Past 10 Years
Min: -241.63   Med: 76.36   Max: 250.64
Current: 16.67

During the past 13 years, the highest EV-to-FCF of CK Life Sciences International Holdings was 250.64. The lowest was -241.63. And the median was 76.36.

HKSE:00775's EV-to-FCF is ranked worse than
65.13% of 390 companies
in the Biotechnology industry
Industry Median: 4.475 vs HKSE:00775: 16.67

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-30), CK Life Sciences International Holdings's stock price is HK$0.385. CK Life Sciences International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.002. Therefore, CK Life Sciences International Holdings's PE Ratio for today is 192.50.


CK Life Sciences International Holdings EV-to-FCF Historical Data

The historical data trend for CK Life Sciences International Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings EV-to-FCF Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.20 91.12 60.20 87.48 50.43

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.20 - 87.48 - 50.43

Competitive Comparison of CK Life Sciences International Holdings's EV-to-FCF

For the Biotechnology subindustry, CK Life Sciences International Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's EV-to-FCF falls into.



CK Life Sciences International Holdings EV-to-FCF Calculation

CK Life Sciences International Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8762.987/514.181
=17.04

CK Life Sciences International Holdings's current Enterprise Value is HK$8,763 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CK Life Sciences International Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$514 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings  (HKSE:00775) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CK Life Sciences International Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.385/0.002
=192.50

CK Life Sciences International Holdings's share price for today is HK$0.385.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CK Life Sciences International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


CK Life Sciences International Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (HKSE:00775) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines